Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
SPRUCE BIOSCIENCES, INC. (SPRB)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/14/2023 |
8-K
| Quarterly results |
| 05/26/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 05/25/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/15/2023 |
8-K
| Quarterly results |
| 03/16/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
| 02/09/2023 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ...|
Docs:
|
"PRE-FUNDED WARRANT TO PURCHASE COMMON STOCK SPRUCE BIOSCIENCES, INC. Warrant Shares: [_______] Issue Date: [____], 2023 THIS PRE-FUNDED WARRANT TO PURCHASE COMMON STOCK certifies that, for value received, [_____________] or its assigns is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof and until 5:00 p.m. on [___], 2028 but not thereafter, to subscribe for and purchase from Spruce Biosciences, Inc., a Delaware corporation , up to [______] shares of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2. Section 1. Definitions. In addition to the terms defined elsewhere in this Warrant, the following ter...",
"COMMON STOCK PURCHASE WARRANT SPRUCE BIOSCIENCES, INC. Warrant Shares: [_______] Issue Date: [____], 2023 THIS COMMON STOCK PURCHASE WARRANT certifies that, for value received, [_____________] or its assigns is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof and until 5:00 p.m. on [___], 2028 but not thereafter, to subscribe for and purchase from Spruce Biosciences, Inc., a Delaware corporation , up to [______] shares of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2. Section 1. Definitions. In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicat...",
"SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement , dated as of February 8, 2023, is made by and among Spruce Biosciences, Inc., a Delaware corporation , and the Purchasers listed on hereto, together with their permitted transferees . Recitals A. The Company and the Purchasers are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded by Section 4 of the Securities Act and/or Rule 506 of Regulation D as promulgated by the SEC under the Securities Act. B. The Purchasers, severally, and not jointly, desire to purchase from the Company, and the Company desires to sell to the Purchasers, upon the terms and conditions stated in this Agreement, shares of the Company’s common stock, par value $0.0001 per share , to certain Purch..." |
|
| 01/09/2023 |
8-K
| Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Other Events, Financial Statements... |
| 12/02/2022 |
8-K
| Quarterly results |
| 11/10/2022 |
8-K
| Quarterly results |
| 08/10/2022 |
8-K
| Quarterly results |
| 05/27/2022 |
8-K
| Quarterly results |
| 05/11/2022 |
8-K
| Quarterly results |
| 04/08/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 03/14/2022 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 03/14/2022 |
8-K
| Quarterly results |
| 01/05/2022 |
8-K
| Results of Operations and Financial Condition, Departure of Directors or Certain Officers; Election of Directors; Appointment...|
Docs:
|
"Offer Letter, by and between the Company and Javier Szwarcberg, M.D., MPH",
"Form of Stock Option Grant Notice, Option Agreement and Notice of Exercise for Inducement Grant Outside of the Spruce Biosciences, Inc. 2020 Equity Incentive Plan",
"Spruce Biosciences Appoints Javier Szwarcberg, M.D., MPH as Chief Executive Officer – Samir Gharib, MBA, Promoted to President –" |
|
| 09/15/2021 |
8-K
| Quarterly results |
| 08/25/2021 |
8-K
| Quarterly results |
| 08/10/2021 |
8-K
| Quarterly results |
| 06/29/2021 |
8-K
| Quarterly results |
| 05/24/2021 |
8-K
| Quarterly results |
| 05/12/2021 |
8-K
| Quarterly results |
| 03/22/2021 |
8-K
| Quarterly results |
| 02/25/2021 |
8-K
| Quarterly results |
| 01/06/2021 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits |
| 11/18/2020 |
8-K
| Quarterly results |
| 10/14/2020 |
8-K
| Quarterly results |
|
|